Login to Your Account

Achillion Gets $10.4M As Part Of Series D, Names New CEO

By Kim Coghill

Friday, September 3, 2004
Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription